{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T11:57:32Z","timestamp":1759838252430,"version":"3.41.0"},"reference-count":101,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:p>Lorcaserin is a modestly selective agonist for 2C serotonin receptors (5-HT<jats:sub>2C<\/jats:sub>R). Despite early promising data, it recently failed to facilitate cocaine abstinence in patients and has been compared with dopamine antagonist medications (antipsychotics). Here, we review the effects of both classes on drug reinforcement. In addition to not being effective treatments for cocaine use disorder, both dopamine antagonists and lorcaserin can have biphasic effects on dopamine and reward behavior. Lower doses can cause enhanced drug taking with higher doses causing reductions. This biphasic pattern is shared with certain stimulants, opioids, and sedative-hypnotics, as well as compounds without abuse potential that include agonists for muscarinic and melatonin receptors. Additional factors associated with decreased drug taking include intermittent dosing for dopamine antagonists and use of progressive-ratio schedules for lorcaserin. Clinically relevant doses of lorcaserin were much lower than those that inhibited cocaine-reinforced behavior and can also augment this same behavior in different species. Diminished drug-reinforced behavior only occurred in animals after higher doses that are not suitable for use in patients. In conclusion, drugs of abuse and related compounds often act as biphasic modifiers of reward behavior, especially when evaluated over a broad range of doses. This property may reflect the underlying physiology of the reward system, allowing homeostatic influences on behavior.<\/jats:p>","DOI":"10.1097\/fbp.0000000000000672","type":"journal-article","created":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T21:28:52Z","timestamp":1648157332000},"page":"238-248","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Biphasic reward effects are characteristic of both lorcaserin and drugs of abuse: implications for treatment of substance use disorders"],"prefix":"10.1097","volume":"33","author":[{"given":"Ken W.","family":"Grasing","sequence":"first","affiliation":[{"name":"Substance Use Research Laboratory, Research Service, Kansas City Veterans Affairs Medical Center, Kansas City, Missouri"},{"name":"Division of Clinical Pharmacology, Department of Medicine, University of Kansas School of Medicine, Kansas City, Kansas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"Burnell","sequence":"additional","affiliation":[{"name":"Substance Use Research Laboratory, Research Service, Kansas City Veterans Affairs Medical Center, Kansas City, Missouri"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alok","family":"De","sequence":"additional","affiliation":[{"name":"Substance Use Research Laboratory, Research Service, Kansas City Veterans Affairs Medical Center, Kansas City, Missouri"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,3,23]]},"reference":[{"key":"R1-20250614","doi-asserted-by":"crossref","first-page":"108321","DOI":"10.1016\/j.drugalcdep.2020.108321","article-title":"Opioid-related overdose mortality in the era of fentanyl: monitoring a shifting epidemic by person, place, and time.","volume":"216","author":"Althoff","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"R2-20250614","doi-asserted-by":"crossref","first-page":"108009","DOI":"10.1016\/j.neuropharm.2020.108009","article-title":"Suppression of cocaine relapse-like behaviors upon pimavanserin and lorcaserin co-administration.","volume":"168","author":"Anastasio","year":"2020","journal-title":"Neuropharmacology"},{"key":"R3-20250614","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1369-1600.2011.00368.x","article-title":"Diazepam promotes choice of abstinence in cocaine self-administering rats.","volume":"17","author":"Augier","year":"2012","journal-title":"Addict Biol"},{"key":"R4-20250614","first-page":"495","article-title":"Fifty years chlorpromazine: a historical perspective.","volume":"3","author":"Ban","year":"2007","journal-title":"Neuropsychiatr Dis Treat"},{"key":"R5-20250614","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1038\/npp.2016.259","article-title":"Repeated 7-day treatment with the 5-HT2C agonist lorcaserin or the 5-HT2A antagonist pimavanserin alone or in combination fails to reduce cocaine vs food choice in male rhesus monkeys.","volume":"42","author":"Banks","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"R6-20250614","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s00213-002-1079-1","article-title":"Enhancement of cocaine-seeking behavior by repeated nicotine exposure in rats.","volume":"162","author":"Bechtholt","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"R7-20250614","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13011-021-00415-5","article-title":"Trends in healthcare expenditures and resource utilization among a nationally representative population with opioids in the United States: a serial cross-sectional study, 2008 to 2017.","volume":"16","author":"Bounthavong","year":"2021","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"R8-20250614","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1021\/acschemneuro.8b00258","article-title":"Classics in chemical neuroscience: chlorpromazine.","volume":"10","author":"Boyd-Kimball","year":"2019","journal-title":"ACS Chem Neurosci"},{"key":"R9-20250614","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/0024-3205(81)90519-1","article-title":"Heroin reward is dependent on a dopaminergic substrate.","volume":"29","author":"Bozarth","year":"1981","journal-title":"Life Sci"},{"key":"R10-20250614","doi-asserted-by":"crossref","first-page":"107859","DOI":"10.1016\/j.drugalcdep.2020.107859","article-title":"Effects of lorcaserin on oxycodone self-administration and subjective responses in participants with opioid use disorder.","volume":"208","author":"Brandt","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"R11-20250614","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0079-6123(08)00916-3","article-title":"Prospects for serotonin 5-HT2R pharmacotherapy in psychostimulant abuse.","volume":"172","author":"Bubar","year":"2008","journal-title":"Prog Brain Res"},{"key":"R12-20250614","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0022-3565(25)22355-2","article-title":"Effects of dopamine D-1 and D-2 antagonists on cocaine self-administration under different schedules of reinforcement in the rat.","volume":"270","author":"Caine","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"R13-20250614","first-page":"CD007380","article-title":"Psychostimulant drugs for cocaine dependence.","volume":"9","author":"Castells","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"R14-20250614","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1007\/s11606-019-05074-8","article-title":"Pharmacotherapy for cocaine use disorder-a systematic review and meta-analysis.","volume":"34","author":"Chan","year":"2019","journal-title":"J Gen Intern Med"},{"key":"R15-20250614","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1037\/pha0000209","article-title":"Effects of lorcaserin and buspirone, administered alone and as a mixture, on cocaine self-administration in male and female rhesus monkeys.","volume":"26","author":"Collins","year":"2018","journal-title":"Exp Clin Psychopharmacol"},{"key":"R16-20250614","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1124\/jpet.115.228833","article-title":"Lorcaserin reduces the discriminative stimulus and reinforcing effects of cocaine in rhesus monkeys.","volume":"356","author":"Collins","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"key":"R17-20250614","doi-asserted-by":"crossref","first-page":"107915","DOI":"10.1016\/j.neuropharm.2019.107915","article-title":"Lorcaserin bidirectionally regulates dopaminergic function site-dependently and disrupts dopamine brain area correlations in rats.","volume":"166","author":"De Deurwaerd\u00e8re","year":"2020","journal-title":"Neuropharmacology"},{"key":"R18-20250614","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1037\/h0081662","article-title":"Blockade of cocaine reinforcement in rats with the dopamine receptor blocker pimozide, but not with the noradrenergic blockers phentolamine or phenoxybenzamine.","volume":"31","author":"De Wit","year":"1977","journal-title":"Can J Psychol"},{"key":"R19-20250614","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0376-8716(95)01118-I","article-title":"The role of dopamine in drug abuse viewed from the perspective of its role in motivation.","volume":"38","author":"Di Chiara","year":"1995","journal-title":"Drug Alcohol Depend"},{"key":"R20-20250614","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.pbb.2018.11.002","article-title":"Persistent attenuation of nicotine self-administration in rats by co-administration of chronic nicotine infusion with the dopamine D1 receptor antagonist SCH-23390 or the serotonin 5-HT2C agonist lorcaserin.","volume":"176","author":"DiPalma","year":"2019","journal-title":"Pharmacol Biochem Behav"},{"key":"R21-20250614","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/BF00428151","article-title":"Heroin and cocaine intravenous self-administration in rats: mediation by separate neural systems.","volume":"78","author":"Ettenberg","year":"1982","journal-title":"Psychopharmacology (Berl)"},{"key":"R22-20250614","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0376-8716(01)00129-6","article-title":"Effect of flupenthixol on subjective and cardiovascular responses to intravenous cocaine in humans.","volume":"64","author":"Evans","year":"2001","journal-title":"Drug Alcohol Depend"},{"key":"R23-20250614","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S1734-1140(09)70132-X","article-title":"Overview on 5-HT receptors and their role in physiology and pathology of the central nervous system.","volume":"61","author":"Filip","year":"2009","journal-title":"Pharmacol Rep"},{"key":"R25-20250614","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.pnpbp.2007.01.025","article-title":"Haloperidol (but not ziprasidone) withdrawal enhances cocaine-induced locomotor activation and conditioned place preference in mice.","volume":"31","author":"Fukushiro","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R26-20250614","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1124\/jpet.116.236307","article-title":"Effects of lorcaserin on cocaine and methamphetamine self-administration and reinstatement of responding previously maintained by cocaine in rhesus monkeys.","volume":"359","author":"Gerak","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"key":"R27-20250614","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0006-8993(01)03105-5","article-title":"Decrease in basal dopamine levels in the nucleus accumbens shell during daily drug-seeking behaviour in rats.","volume":"924","author":"Gerrits","year":"2002","journal-title":"Brain Res"},{"key":"R28-20250614","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s002130050144","article-title":"Effects of drugs on food- and cocaine-maintained responding, III: dopaminergic antagonists.","volume":"128","author":"Glowa","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"key":"R29-20250614","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bbr.2016.06.022","article-title":"A threshold model for opposing actions of acetylcholine on reward behavior: molecular mechanisms and implications for treatment of substance abuse disorders.","volume":"312","author":"Grasing","year":"2016","journal-title":"Behav Brain Res"},{"key":"R30-20250614","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/FBP.0000000000000472","article-title":"The muscarinic agonist pilocarpine modifies cocaine-reinforced and food-reinforced responding in rats: comparison with the cholinesterase inhibitor tacrine.","volume":"30","author":"Grasing","year":"2019","journal-title":"Behav Pharmacol"},{"key":"R31-20250614","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/BF02244653","article-title":"Potentiation by low doses of selected neuroleptics of food-induced conditioned place preference in rats.","volume":"110","author":"Guyon","year":"1993","journal-title":"Psychopharmacology (Berl)"},{"key":"R32-20250614","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejphar.2008.07.049","article-title":"Melatonin reverses the expression of morphine-induced conditioned place preference through its receptors within central nervous system in mice.","volume":"594","author":"Han","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"R33-20250614","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00213-011-2231-6","article-title":"Aripiprazole maintenance increases smoked cocaine self-administration in humans.","volume":"216","author":"Haney","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"R34-20250614","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s002130100725","article-title":"Effects of ecopipam, a selective dopamine D1 antagonist, on smoked cocaine self-administration by humans.","volume":"155","author":"Haney","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"R35-20250614","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neuropharm.2015.09.028","article-title":"The 5-HT(2C) receptor agonist lorcaserin reduces cocaine self-administration, reinstatement of cocaine-seeking and cocaine induced locomotor activity.","volume":"101","author":"Harvey-Lewis","year":"2016","journal-title":"Neuropharmacology"},{"key":"R36-20250614","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ejphar.2003.08.102","article-title":"Serotonin and drug reward: focus on 5-HT2C receptors.","volume":"480","author":"Higgins","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"R37-20250614","doi-asserted-by":"crossref","first-page":"107417","DOI":"10.1016\/j.pharmthera.2019.107417","article-title":"Lorcaserin: a review of its preclinical and clinical pharmacology and therapeutic potential.","volume":"205","author":"Higgins","year":"2020","journal-title":"Pharmacol Ther"},{"key":"R38-20250614","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/npp.2011.303","article-title":"The 5-HT2C receptor agonist lorcaserin reduces nicotine self-administration, discrimination, and reinstatement: relationship to feeding behavior and impulse control.","volume":"37","author":"Higgins","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"R39-20250614","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/S0022-3565(25)12217-9","article-title":"Serotonergic modulation of the behavioral effects of cocaine in the squirrel monkey.","volume":"275","author":"Howell","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"R40-20250614","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1124\/pr.114.009514","article-title":"Serotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorder.","volume":"67","author":"Howell","year":"2015","journal-title":"Pharmacol Rev"},{"key":"R41-20250614","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1038\/npp.2009.10","article-title":"Repeated cocaine administration decreases 5-HT(2A) receptor-mediated serotonergic enhancement of synaptic activity in rat medial prefrontal cortex.","volume":"34","author":"Huang","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"R42-20250614","first-page":"CD006306","article-title":"Antipsychotic medications for cocaine dependence.","volume":"3","author":"Indave","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"R43-20250614","doi-asserted-by":"crossref","first-page":"666945","DOI":"10.3389\/fpsyt.2021.666945","article-title":"Safety and preliminary efficacy of lorcaserin for cocaine use disorder: a phase I randomized clinical trial.","volume":"12","author":"Johns","year":"2021","journal-title":"Front Psychiatry"},{"key":"R44-20250614","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/00008877-199000140-00010","article-title":"Effects of continuous infusions of SCH 23390 on cocaine- or food-maintained behavior in rhesus monkeys.","volume":"1","author":"Kleven","year":"1990","journal-title":"Behav Pharmacol"},{"key":"R45-20250614","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejphar.2018.09.025","article-title":"Lorcaserin decreases the reinforcing effects of heroin, but not food, in rhesus monkeys.","volume":"840","author":"Kohut","year":"2018","journal-title":"Eur J Pharmacol"},{"key":"R46-20250614","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0022-3565(24)38019-X","article-title":"Effects of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens.","volume":"288","author":"Kuroki","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"R47-20250614","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0006-8993(84)90223-3","article-title":"The effects of putative 5-hydroxytryptamine receptor active agents on D-amphetamine self-administration in controls and rats with 5,7-dihydroxytryptamine median forebrain bundle lesions.","volume":"303","author":"Leccese","year":"1984","journal-title":"Brain Res"},{"key":"R48-20250614","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.neuropharm.2008.10.005","article-title":"Serotonin2C receptors in the medial prefrontal cortex facilitate cocaine-induced dopamine release in the rat nucleus accumbens.","volume":"56","author":"Leggio","year":"2009","journal-title":"Neuropharmacology"},{"key":"R49-20250614","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1124\/jpet.111.183525","article-title":"Lorcaserin, a 5-HT2C agonist, decreases nicotine self-administration in female rats.","volume":"338","author":"Levin","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"R50-20250614","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ejphar.2008.10.016","article-title":"Ketanserin, a 5-HT2 receptor antagonist, decreases nicotine self-administration in rats.","volume":"600","author":"Levin","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"R51-20250614","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/oby.20429","article-title":"Illicit online marketing of lorcaserin before DEA scheduling.","volume":"21","author":"Liang","year":"2013","journal-title":"Obesity (Silver Spring)"},{"key":"R52-20250614","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.pbb.2008.07.008","article-title":"Diazepam alters cocaine self-administration, but not cocaine-stimulated locomotion or nucleus accumbens dopamine.","volume":"91","author":"Maier","year":"2008","journal-title":"Pharmacol Biochem Behav"},{"key":"R53-20250614","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1176\/ajp.2007.164.4.622","article-title":"Amphetamine-induced dopamine release: markedly blunted in cocaine dependence and predictive of the choice to self-administer cocaine.","volume":"164","author":"Martinez","year":"2007","journal-title":"Am J Psychiatry"},{"key":"R54-20250614","doi-asserted-by":"crossref","first-page":"202","DOI":"10.15585\/mmwr.mm7006a4","article-title":"Trends and geographic patterns in drug and synthetic opioid overdose deaths - United States, 2013-2019.","volume":"70","author":"Mattson","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R55-20250614","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0893-133X(95)00274-H","article-title":"Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures.","volume":"14","author":"Mello","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"R56-20250614","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/S0022-3565(25)10654-X","article-title":"A primate model of polydrug abuse: cocaine and heroin combinations.","volume":"274","author":"Mello","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"R57-20250614","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fnins.2013.00019","article-title":"Unraveling the central proopiomelanocortin neural circuits.","volume":"7","author":"Mercer","year":"2013","journal-title":"Front Neurosci"},{"key":"R59-20250614","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1111\/j.1471-4159.1990.tb01230.x","article-title":"Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study.","volume":"54","author":"Moghaddam","year":"1990","journal-title":"J Neurochem"},{"key":"R60-20250614","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s002130100724","article-title":"Repeated administration of the D1\/5 antagonist ecopipam fails to attenuate the subjective effects of cocaine.","volume":"155","author":"Nann-Vernotica","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"R62-20250614","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/sj.npp.1301414","article-title":"Differential regulation of the mesoaccumbens dopamine circuit by serotonin2C receptors in the ventral tegmental area and the nucleus accumbens: an in vivo microdialysis study with cocaine.","volume":"33","author":"Navailles","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"R63-20250614","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1021\/acschemneuro.6b00413","article-title":"Lorcaserin suppresses oxycodone self-administration and relapse vulnerability in rats.","volume":"8","author":"Neelakantan","year":"2017","journal-title":"ACS Chem Neurosci"},{"key":"R64-20250614","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1038\/s41386-020-00815-4","article-title":"Learning from lorcaserin: lessons from the negative clinical trial of lorcaserin to treat cocaine use disorder.","volume":"45","author":"Negus","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"R65-20250614","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s00213-003-1409-y","article-title":"Effects of chronic d-amphetamine treatment on cocaine- and food-maintained responding under a progressive-ratio schedule in rhesus monkeys.","volume":"167","author":"Negus","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"key":"R66-20250614","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0022-3565(25)20676-0","article-title":"Acute and chronic effects of flupenthixol on the discriminative stimulus and reinforcing effects of cocaine in rhesus monkeys.","volume":"278","author":"Negus","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"R68-20250614","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1017\/S1461145708009097","article-title":"Evaluation of subjective effects of aripiprazole and methamphetamine in methamphetamine-dependent volunteers.","volume":"11","author":"Newton","year":"2008","journal-title":"Int J Neuropsychopharmacol"},{"key":"R69-20250614","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1007\/s00213-017-4726-2","article-title":"Choice between delayed food and immediate opioids in rats: treatment effects and individual differences.","volume":"234","author":"Panlilio","year":"2017","journal-title":"Psychopharmacology (Berl)"},{"key":"R70-20250614","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/add.15222","article-title":"The dawn of a new synthetic opioid era: the need for innovative interventions.","volume":"116","author":"Pardo","year":"2021","journal-title":"Addiction"},{"key":"R71-20250614","doi-asserted-by":"crossref","first-page":"602","DOI":"10.5607\/en.2019.28.5.602","article-title":"Combination of in vivo [123I]FP-CIT SPECT and microdialysis reveals an antipsychotic drug haloperidol-induced synaptic dopamine availability in the rat midbrain and striatum.","volume":"28","author":"Park","year":"2019","journal-title":"Exp Neurobiol"},{"key":"R72-20250614","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1176\/ajp.137.12.1518","article-title":"Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency.","volume":"137","author":"Peroutka","year":"1980","journal-title":"Am J Psychiatry"},{"key":"R73-20250614","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.pbb.2019.02.010","article-title":"The serotonin-2C agonist Lorcaserin delays intravenous choice and modifies the subjective and cardiovascular effects of cocaine: a randomized, controlled human laboratory study.","volume":"180","author":"Pirtle","year":"2019","journal-title":"Pharmacol Biochem Behav"},{"key":"R74-20250614","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00213-002-1137-8","article-title":"Behavioral effects of cocaine and dopaminergic strategies for preclinical medication development.","volume":"163","author":"Platt","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"R75-20250614","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0169-328X(94)90223-2","article-title":"Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors.","volume":"23","author":"Pompeiano","year":"1994","journal-title":"Brain Res Mol Brain Res"},{"key":"R76-20250614","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00004714-199906000-00003","article-title":"Psychomotor, cognitive, extrapyramidal, and affective functions of healthy volunteers during treatment with an atypical (amisulpride) and a classic (haloperidol) antipsychotic.","volume":"19","author":"Ramaekers","year":"1999","journal-title":"J Clin Psychopharmacol"},{"key":"R77-20250614","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0376-8716(94)90005-1","article-title":"A single injection of either flupenthixol decanoate or haloperidol decanoate produces long-term changes in cocaine self-administration in rats.","volume":"36","author":"Richardson","year":"1994","journal-title":"Drug Alcohol Depend"},{"key":"R78-20250614","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1749-6632.1988.tb42125.x","article-title":"Neuroleptic binding to human brain receptors: relation to clinical effects.","volume":"537","author":"Richelson","year":"1988","journal-title":"Ann N Y Acad Sci"},{"key":"R79-20250614","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0091-3057(94)90473-1","article-title":"Lesions of central serotonin systems affect responding on a progressive ratio schedule reinforced either by intravenous cocaine or by food.","volume":"49","author":"Roberts","year":"1994","journal-title":"Pharmacol Biochem Behav"},{"key":"R80-20250614","doi-asserted-by":"crossref","first-page":"10039","DOI":"10.1523\/JNEUROSCI.22-22-10039.2002","article-title":"Enhanced locomotor, reinforcing, and neurochemical effects of cocaine in serotonin 5-hydroxytryptamine 2C receptor mutant mice.","volume":"22","author":"Rocha","year":"2002","journal-title":"J Neurosci"},{"key":"R81-20250614","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1001\/archpsyc.56.12.1101","article-title":"Attenuation of the euphoric effects of cocaine by the dopamine D1\/D5 antagonist ecopipam (SCH 39166).","volume":"56","author":"Romach","year":"1999","journal-title":"Arch Gen Psychiatry"},{"key":"R82-20250614","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0163-7258(98)00019-9","article-title":"5-hydroxytryptamine2-family receptors (5-hydroxytryptamine2A, 5-hydroxytryptamine2B, 5-hydroxytryptamine2C): where structure meets function.","volume":"79","author":"Roth","year":"1998","journal-title":"Pharmacol Ther"},{"key":"R83-20250614","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.pnpbp.2013.07.006","article-title":"Are dopamine D2 receptors out of control in psychosis?","volume":"46","author":"Seeman","year":"2013","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R84-20250614","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1056\/NEJMp2003873","article-title":"Cancer risk associated with lorcaserin - the FDA\u2019s review of the CAMELLIA-TIMI 61 trial.","volume":"383","author":"Sharretts","year":"2020","journal-title":"N Engl J Med"},{"key":"R85-20250614","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0165-1781(89)90127-3","article-title":"Effects of intravenous cocaine are partially attenuated by haloperidol.","volume":"27","author":"Sherer","year":"1989","journal-title":"Psychiatry Res"},{"key":"R86-20250614","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/clpt.2011.20","article-title":"Evaluation of the abuse potential of lorcaserin, a serotonin 2C (5-HT2C) receptor agonist, in recreational polydrug users.","volume":"89","author":"Shram","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"R87-20250614","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF03394158","article-title":"Haloperidol effects on morphine self-administration: testing for pharmacological modification of the primary reinforcement mechanism.","volume":"23","author":"Smith","year":"1973","journal-title":"Psychol Rec"},{"key":"R89-20250614","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/BF00427827","article-title":"Attenuation of heroin reward in rats by disruption of the mesolimbic dopamine system.","volume":"79","author":"Spyraki","year":"1983","journal-title":"Psychopharmacology (Berl)"},{"key":"R90-20250614","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/bs.pbr.2021.02.003","article-title":"Anatomical and neurochemical organization of the serotonergic system in the mammalian brain and in particular the involvement of the dorsal raphe nucleus in relation to neurological diseases.","volume":"261","author":"Steinbusch","year":"2021","journal-title":"Prog Brain Res"},{"key":"R91-20250614","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0006-3223(89)90052-8","article-title":"Chronic flupentixol treatment potentiates the reinforcing properties of systemic heroin administration.","volume":"26","author":"Stinus","year":"1989","journal-title":"Biol Psychiatry"},{"key":"R92-20250614","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1080\/00952990701651556","article-title":"The safety, tolerability, and subject-rated effects of acute intranasal cocaine administration during aripiprazole maintenance.","volume":"33","author":"Stoops","year":"2007","journal-title":"Am J Drug Alcohol Abuse"},{"key":"R93-20250614","doi-asserted-by":"crossref","first-page":"3732","DOI":"10.2174\/1381612821666150605111236","article-title":"Atypical antipsychotics and inverse agonism at 5-HT2 receptors.","volume":"21","author":"Sullivan","year":"2015","journal-title":"Curr Pharm Des"},{"key":"R94-20250614","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/374542a0","article-title":"Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors.","volume":"374","author":"Tecott","year":"1995","journal-title":"Nature"},{"key":"R95-20250614","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00127-019-01819-2","article-title":"Experiences of taking neuroleptic medication and impacts on symptoms, sense of self and agency: a systematic review and thematic synthesis of qualitative data.","volume":"55","author":"Thompson","year":"2020","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"R96-20250614","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1124\/jpet.107.133348","article-title":"Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization.","volume":"325","author":"Thomsen","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"R97-20250614","doi-asserted-by":"crossref","first-page":"107848","DOI":"10.1016\/j.drugalcdep.2020.107848","article-title":"Lorcaserin maintenance fails to attenuate heroin vs. food choice in rhesus monkeys.","volume":"208","author":"Townsend","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"R98-20250614","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/npp.2016.264","article-title":"Activation of ventral tegmental area 5-HT2C receptors reduces incentive motivation.","volume":"42","author":"Valencia-Torres","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"R99-20250614","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/schbul\/sby052","article-title":"Clozapine and long-term mortality risk in patients with schizophrenia: a systematic review and meta-analysis of studies lasting 1.1-12.5 years.","volume":"45","author":"Vermeulen","year":"2019","journal-title":"Schizophr Bull"},{"key":"R100-20250614","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00213-011-2368-3","article-title":"Effects of antipsychotic treatment on psychopathology and motor symptoms. A placebo-controlled study in healthy volunteers.","volume":"218","author":"Veselinovi\u0107","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"R101-20250614","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/386830a0","article-title":"Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects.","volume":"386","author":"Volkow","year":"1997","journal-title":"Nature"},{"key":"R102-20250614","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0304-3940(89)90289-9","article-title":"On the mechanism of neuroleptic induced increase in striatal dopamine release: brain dialysis provides direct evidence for mediation by autoreceptors localized on nerve terminals.","volume":"99","author":"Westerink","year":"1989","journal-title":"Neurosci Lett"},{"key":"R103-20250614","doi-asserted-by":"crossref","first-page":"172766","DOI":"10.1016\/j.pbb.2019.172766","article-title":"Acute and chronic interactive treatments of serotonin 5HT2C and dopamine D1 receptor systems for decreasing nicotine self-administration in female rats.","volume":"186","author":"Willette","year":"2019","journal-title":"Pharmacol Biochem Behav"},{"key":"R104-20250614","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1517\/13543784.16.6.771","article-title":"Aripiprazole acts as a selective dopamine D2 receptor partial agonist.","volume":"16","author":"Wood","year":"2007","journal-title":"Expert Opin Investig Drugs"},{"key":"R105-20250614","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1600-079X.2007.00422.x","article-title":"Melatonin enhances the rewarding properties of morphine: involvement of the nitric oxidergic pathway.","volume":"42","author":"Yahyavi-Firouz-Abadi","year":"2007","journal-title":"J Pineal Res"},{"key":"R106-20250614","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1126\/science.1114313","article-title":"Increased lever pressing for amphetamine after pimozide in rats: implications for a dopamine theory of reward.","volume":"187","author":"Yokel","year":"1975","journal-title":"Science"}],"container-title":["Behavioural Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FBP.0000000000000672","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T22:01:33Z","timestamp":1749938493000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FBP.0000000000000672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,23]]},"references-count":101,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/fbp.0000000000000672","relation":{},"ISSN":["0955-8810"],"issn-type":[{"type":"print","value":"0955-8810"}],"subject":[],"published":{"date-parts":[[2022,3,23]]}}}